You have a lot to protect, bank more than cord blood.

The Potential of Mesenchymal-Like Stem Cells

More peace of mind by banking from 2 lifesaving sources.

Specific stem cells called mesenchymal* cells may prove useful for regenerative medicine treatments. In the laboratory, scientists have learned that mesenchymal stem cells have strong potential to repair bones and regrow cartilage.1-4 Placental and cord blood contain mesenchymal-like stem cells, including CD105+200+ cells.4,5,† And only LifebankUSA maximizes the collection of these cells through Placental and Cord Blood Banking.

Your child is being born into a world of extraordinary medical possibilities. And when it comes to possibilities, LifebankUSA is leading the way.

"If you have a patient who has organ failure, you don't want that patient to die because you're waiting for an organ. People are dying every day on the transplant wait list. So the hope of the field is that someday we can provide replacement tissues and organs that can be used to help them survive."
- Dr. Anthony Atala
Wake Forest Institute for Regenerative Medicine
North Carolina
Speaking on "60 Minutes"
Available at http://www.cbsnews.com/stories/2010/07/21/60minutes/main6698375.shtml
*Mesenchymal is pronounced muh-ZINK-i-mul. Mesenchymal cells are cells capable of differentiating into various mesenchymal tissues, such as bone, cartilage, fat, tendon, and muscle.
† Data on file, LifebankUSA; 2010.
Cord blood and placenta-derived stem cells banked with LifebankUSA are indicated for hematopoietic reconstitution (the reformation of blood cellular components) for autologous use or use in first or second degree blood relatives. Any use of cord blood and placental stem cells other than for hematopoietic reconstitution is considered investigational, including regenerative medicine* therapies.

The chance that a child will use his/her own stored stem cells during his/her lifetime for currently treated conditions is estimated at 1 in 400.† These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the stem cells collected, the HLA compatibility between recipient and donor, and the client's overall health. Talk with your health care provider. For more information, call us at 1-877-LIFEBANKUSA ( 1-877-543-3226 ).

*These uses are not consistent with current labeling, are investigational and may never become standard therapy.
† Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant. 2008;14(3):316-322.

References:
  1. Harris DT. Non-haematological uses of cord blood stem cells. Br J Haematol. 2009;147(2):177-184.
  2. Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A. Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol. 2010;222(1):23-32.
  3. Yen BL, Huang H-I, Chien C-C, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005;23(1):3-9.
  4. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26(9):2287-2299.
  5. Data on file, LifebankUSA; 2010.